Jvion Releases 2021 Predictions: Value-Based Care, Consumerism, Behavioral Health, and Social Determinants to Drive Clinical AI Adoption
ATLANTA, Dec. 2, 2020 /PRNewswire-PRWeb/ -- Jvion, a leader in prescriptive clinical artificial intelligence (AI), today announced their predictions for healthcare in 2021. As the outcome of the 2020 election comes into focus and the pandemic surges to its most severe stage yet, both factors will weigh heavily on the direction of healthcare in the year to come.
"With the election decided, it's clear that health system revenue will continue to shift to value-based care models," said Dr. John Showalter, Jvion's Chief Product Officer. "Once it reaches a tipping point of 50% of total revenue, providers' financial performance will be inextricably linked to their patients' outcomes."
"To survive, providers and payers will need to harness their data to predict and mitigate patient risk, and prescriptive clinical AI will be an essential capability," adds Dr. John Frownfelter, Jvion's Chief Medical Information Officer. "And with a new surge in Covid-19 extending the toll on health systems through at least early 2022, clinical AI will be more essential than ever to prevent negative quality events and keep costs down."
In this context, Dr. Frownfelter and Dr. Showalter predict four key trends will drive change in healthcare in 2021:
Value-based care accelerates, hinging on election and Supreme Court outcomes.
-- A Joe Biden presidency will likely accelerate the trend towards
value-based care, with the pace depending on who ultimately controls the
Senate following runoff races in Georgia. Democratic control will likely
lead to a stronger legislative push for capitation over fee-for-service
models, while divided government may limit action to the executive
agency level. The Supreme Court will also impact this trend if the ACA's
value-based incentives are upheld or overruled.
Consumerism will drive greater transparency in clinical AI applications.
-- As patients shoulder an increasing burden of healthcare costs, and new
HHS rules require greater price transparency, patients will be more
engaged in their care and demand to know why costly procedures and
services are necessary. This trend will drive healthcare payers to
invest in prescriptive clinical AI platforms that deliver personalized
care plans and engagement recommendations for their members. With more
transparency around the use of clinical AI, patients will better
understand their risk and be empowered to take action to reduce their
risk.
Clinical AI adoption will expand for behavioral health use cases.
-- The pandemic has fueled a national mental health crisis, with 40.9% of
Americans showing signs of adverse mental or behavioral health
conditions. Combined with the shift to value-based reimbursement models,
these trends will drive more behavioral health providers to adopt
prescriptive clinical AI solutions to predict which patients are at risk
and apply clinically-validated interventions to prevent adverse
behavioral health outcomes.
Pandemic economy will intensify impact of social determinants on health outcomes.
-- 8 million Americans have been driven to poverty since the pandemic
recession began. This means social determinants of health (SDOH), such
as unemployment, housing instability and malnutrition, will have a
greater impact on patient outcomes in 2021. To improve outcomes,
providers will need to better understand the social and economic needs
of individual patients, how they impact their risk, and what resources
can be leveraged to address their needs. Prescriptive clinical AI will
be a valuable tool for delivering these population health insights.
About Jvion:
Jvion, a leader in clinical artificial intelligence, enables providers, payers and other healthcare entities to identify and prevent avoidable patient harm, utilization and costs. An industry first, the Jvion CORE(TM) goes beyond predictive analytics and machine learning to identify patients on a trajectory to becoming high-risk. Jvion then determines the interventions that will more effectively reduce risk and enable clinical and operational action. The CORE accelerates time to value by leveraging established patient-level intelligence to drive engagement across healthcare organizations, populations, and individuals. To date, the Jvion CORE has been deployed across hundreds of clients and resulted in millions saved. For more information, visit https://www.jvion.com.
Jvion PR Contact:
Lexi Herosian
lexi@scratchmm.com
Media Contact
Lexi Herosian, Scratch Marketing + Media, 6179459296, lexi@scratchmm.com
SOURCE Jvion
